Latest Non-steroidal anti-inflammatory drugs Stories
New research from the British universities Newcastle and Leeds suggest that taking two aspirin a day for two years reduces the long-term risk of hereditary colon cancer by as much as 60 percent.
The Consumer Justice Foundation, which publishes several free online resources designed to provide consumers with information regarding dealing with corporations and the potential dangers of prescription
Use of acetaminophen and nonaspirin nonsteroidal anti-inflammatory drugs was associated with a significantly increased risk for developing renal cell carcinoma.
Postmenopausal women who reported having used nonsteroidal anti-inflammatory drugs for at least 10 years at the time of enrollment in the Women's Health Initiative study had a lower risk for death from colorectal cancer compared with women who reported no use of these drugs at enrollment.
An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen and low dose ibuprofen are least likely to increase cardiovascular risk whereas diclofenac, even in doses available without prescription, elevates risk.
An updated study gives new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that naproxen, a commonly used drug, and low dose ibuprofen are least likely to increase cardiovascular risks.
A new study from Rhode Island Hospital researchers suggests that controlling cholesterol may be important for heart health in patients who are taking non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen.
Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.
- An armed gangster.
More Images (1 images) »